HC Wainwright & Co. Initiates Coverage On Achieve Life Sciences with Buy Rating, Announces Price Target of $12
Author: Benzinga Newsdesk | August 21, 2025 06:10am
HC Wainwright & Co. analyst Brandon Folkes initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Buy rating and announces Price Target of $12.